Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

FAMU Professor and Engineering Student Named Fulbright Scholars
  • USA - English


News provided by

Florida Agricultural and Mechanical University

Jul 30, 2014, 07:00 ET

Share this article

Share toX

Share this article

Share toX

FAMU Biochemistry Professor Ngozi Ugochukwu, Ph.D. will study diabetes in Nigeria through a Fulbright grant.
FAMU Biochemistry Professor Ngozi Ugochukwu, Ph.D. will study diabetes in Nigeria through a Fulbright grant.

Tallahassee, FL (PRWEB) July 30, 2014 -- Florida A&M University (FAMU) mechanical engineering doctoral candidate Renee Gordon and biochemistry professor Ngozi Ugochukwu, Ph.D., will head to Nigeria in August to conduct research as Fulbright Scholars. The prestigious Fulbright Scholars Program is a highly competitive international education exchange program that awards grants to students, faculty or professionals who wish to study, teach and conduct research abroad. Both Gordon and Ugochukwu will conduct respective research on the indigenous resources of Nigeria.

Diabetes is considered by the World Health Organization and International Diabetes Foundation as one of the major threats to human health in the 21st century. - Ngozi Ugochukwu, Ph.D.

Post this

Gordon is the first student in the FAMU-FSU College of Engineering to receive the Fulbright grant. Her research will focus on using biomass, specifically Nigeria’s cassava leaves, as a green alternative to case hardening steel. She will reside at Nigeria’s Federal University of Technology (FUT) in Akure, which partners with FAMU in a mutual teaching and research exchange program.

According to Gordon, receiving the Fulbright grant brings her closer to fulfilling her desire to do something “forward thinking and innovative” with the indigenous resources of Nigeria. Her goal upon completing her Ph.D. is to work in green engineering with a focus on sustainable and alternative energy and to eventually return to FAMU as a professor to share her knowledge and experiences with others.

“It’s about using sustainable materials and resources that don’t take away from our fossil fuels and using materials that can be regenerated and regrown,” said Gordon about the focus of her research, which picks up where her mentor and research supervisor Peter Kalu, Ph.D. left off.

Gordon is a first generation American citizen by way of Jamaica, and first generation college graduate. She said receiving the Fulbright grant is a milestone in the progress of her research after having to overcome several obstacles in order to continue her work.

Ugochukwu will also complete her research in Nigeria at FUT in Minna. Her research will focus on ethnopharmacology, the study of ethnic groups and their use of drugs. She will also conduct research on bioactive compounds and their role as leads for drug discovery, and uses for traditional medicine in diabetes therapy.

Ugochukwu has been researching diabetes since her tenure began at FAMU in 1998. Her expertise includes the use of biochemical and gene technology techniques in deciphering the underlying mechanisms in the pathophysiology of chronic diseases, such as diabetes, obesity, congestive heart failure and colon cancer. Her research focus also includes finding effective preventive strategies and therapies for these diseases.

“Diabetes is considered by the World Health Organization and International Diabetes Foundation as one of the major threats to human health in the 21st century,” said Ugochukwu. “The Fulbright grant will give me the opportunity to collaborate with researchers at the FUT Minna Center for Genetic Engineering and Biotechnology and the Global Institute for Bio-exploration to scientifically screen and identify anti-diabetic bioactive phytonutrients in indigenous Nigerian plants.”

According to Ugochukwu, this collaborative research could accelerate the discovery and development of new phytopharmaceuticals for diabetes therapy. In addition to her research, Ugochukwu will teach classes in biochemical pharmacology, clinical biochemistry and biochemistry laboratory including virtual proteomics exercises.

She attributes much of her success in research to the support of the FAMU research community, especially her students.

“I am elated about my selection as a Fulbright grantee,” Ugochukwu said. “It’s quite an honor to be recognized by this prestigious body. However, I must attribute this to the collaborative research work my graduate students and I have conducted on chronic diseases over the years at FAMU.”

About Florida Agricultural and Mechanical University

Founded in 1887, Florida Agricultural and Mechanical University (FAMU) is an 1890 land-grant and research institution offering more than 90 baccalaureate, master’s and doctoral degree programs. FAMU is a member of the State University System of Florida and is accredited by the Southern Association of Colleges and Schools Commission on Colleges. The university serves nearly 11,000 students from more than 70 countries.

-30-

Alonda Thomas, Florida Agricultural and Mechanical University, http://www.famu.edu, +1 (850) 412-5211, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.